Climate change and its associated stressors have significantly impacted the freshwater and marine ecosystems worldwide. Increased cases of moderate to extreme weather conditions like heavy rainfalls, warmer coastal temperatures, warmer seawater temperature, decreased salinity, etc., in combination with anthropogenic contributions, have led to increased occurrences of cyanotoxin-producing harmful algal blooms in freshwater and a rising number of non-cholera vibriosis cases. Exposure to these climate change-associated stressors has a significant influence on public health but is presumed to be more severe towards susceptible individuals, including children, the aged population, immunocompromised individuals, and patients with pre-existing chronic disease conditions.Several published studies from our research group have shown that environmental toxins and contaminants can greatly affect the liver, causing the worsening of the so-called silent and benign steatosis stage to a more inflammatory steatohepatitis stage with the onset of scar tissue formation. However, we also found significant knowledge gaps in the existing literature. Moreover, we also wanted to explore the role of the gut microbiota and whether these cyanotoxin exposures had any significant impact on it.
In the first study, we established a murine model of early life exposure to the cyanotoxin microcystin-LR and also parallelly used a separate humanized mice model to translate our findings. Our results showed that early-life MC exposure could impart significant changes in the gut microbiota and increase the abundance of antibiotic-resistance genes. Furthermore, this early-life MC exposure further augmented significant changes in intestinal immunosurveillance and showed elevated systemic inflammation with increased immunosenescence. Therefore, the study provided a breakthrough in cyanotoxin-mediated changes in the gut resitome and its association with the immune markers.
In the second study, we wanted to explore the role of another subchronic cyanotoxin (cylindrospermopsin) exposure on gut microbiota by using a murine model of subchronic exposure. Our data detected that the toxin exposures significantly reshaped the gut bacteriome profile and increased endotoxemia levels that further contributed to the overall hepatotoxicity. These findings were the first proof that established the role of cylindrospermopsin in mediating gut microbiome alterations.
In the third study, we further wanted to follow up on these findings and aimed to explore CYN-mediated toxicity in underlying chronic liver disease conditions. For these purposes, we used a diet-induced murine model to mimic the conditions in humans and subjected the mice to a similar subchronic cylindrospermopsin exposure. The study results showed that CYN treatment caused a significantly increased formation of peroxynitrite, a major cellular oxidant species, leading to increased inflammasome activation, inflammation, and early onset of fibrosis similar to steatohepatitis-like pathology. Administration of different redox inhibitors in these obese mice showed improved pathophysiological outcomes, further confirming the role of peroxynitrite formation and providing a novel mechanistic insight regarding cylindropsermopsin-mediated hepatotoxicity in underlying chronic liver disease conditions.
In the fourth study, we wanted to establish the role of gut microbiota and intestinal homeostasis in causing increased non-cholera vibriosis in a susceptible population like individuals with underlying steatotic liver disease. Similar to the third study, we used another diet-induced murine model to mimic the underlying disease conditions. Our results implicated those mice with underlying obesity had severe vibriosis compared to the lean counterparts, which was further linked to an altered gut microbiota and resistome profile and dysregulation of intestinal homeostasis.